In 2016, the World Health Organization (WHO) updated the classification method for gliomas by combing histological diagnosis with molecular variations such as IDH mutation status and codeletion of the short arm of chromosome 1 and the long arm of chromosome 19 (1p/19q codeletion) (Komori, 2017). This evidence concerns the gene IDH1 and glioma.